RT Book, Section
A1 May, Benjamin J.
A1 Madoff, David C.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145764053
T1 Neuroendocrine Liver Metastases: Thermal Ablation, Transarterial Embolotherapy, and Future Directions
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK accesssurgery.mhmedical.com/content.aspx?aid=1145764053
RD 2024/04/19
AB Neuroendocrine  tumors  (NETs)  represent  a  spectrum  of  histologies  which  share  the  ability  to  secrete  hormonal  or  vasoactive  peptides.1  The  most  common  NETs  are  carcinoid  and  pancreatic  NETs.  At  the  time  of  diagnosis,  liver  metastases  are  common  and  a  negative  predictor  of  survival.2  Furthermore,  liver  metastases  can  cause  debilitating  symptoms  due  to  both  mass  effect  and  secretion  of  vasoactive  peptides.  A  subset  of  these  patients  present  with  the  classic  carcinoid  syndrome  which  includes  diarrhea,  flushing,  bronchospasm,  and  valvular  heart  disease.3